Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.93 USD | +1.87% | +1.41% | +45.20% |
05-02 | Transcript : Kura Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Kura Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.20% | 1.57B | |
+2.74% | 108B | |
+10.08% | 105B | |
+1.57% | 23.46B | |
-11.89% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.95% | 17.19B | |
+5.98% | 13.99B | |
+36.10% | 12.53B |
- Stock Market
- Equities
- KURA Stock
- News Kura Oncology, Inc.
- Kura Oncology : Wedbush Adjusts Kura Oncology's Price Target to $53 From $56, Keeps Outperform Rating